Dr. Rowe is an Associate Professor; Director, The Center for CFTR Detection Core at Children's and UAB; Director, The Cystic Fibrosis Transition Program.
His interests include mechanistic features underlying the correction of mutant cystic fibrosis transmembrane conductance regulator (CFTR) and the design and conduct of clinical trials testing new therapeutic strategies to treat cystic fibrosis. Also evaluation of biomarkers relevant to CFTR activity and clinical outcomes.
